Cargando…

Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit

INTRODUCTION: The Prescribing Observatory for Mental Health initiated a quality improvement (QI) programme on clozapine use in UK mental health services. METHODS: Clinical audits conducted in 2019 and 2021. RESULTS: Sixty-three participating NHS Trusts/healthcare organisations in 2019, and 61 in 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Thomas RE, MacCabe, James H, Kane, John M, Delgado, Oriana, Khan, Mareeha, Paton, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516610/ https://www.ncbi.nlm.nih.gov/pubmed/35695172 http://dx.doi.org/10.1177/02698811221104060

Ejemplares similares

The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services
por: Barnes, Thomas R. E., et al.
Publicado: (2020)

Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit
por: Paton, Carol, et al.
Publicado: (2022)

Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019)

Undertaking clinical audit, with reference to a Prescribing Observatory for Mental Health audit of lithium monitoring
por: Paton, Carol, et al.
Publicado: (2014)

Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)

A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age
por: Paton, Carol, et al.
Publicado: (2018)

Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services
por: Paton, Carol, et al.
Publicado: (2020)

Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice
por: Paton, Carol, et al.
Publicado: (2016)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

41.3 COULD CLOZAPINE REDUCE VIOLENT OFFENDING?
por: Bhavsar, Vishal, et al.
Publicado: (2018)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
por: Verbelen, M, et al.
Publicado: (2015)

The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services
por: Paton, Carol, et al.
Publicado: (2018)

Biological Predictors of Clozapine Response: A Systematic Review
por: Samanaite, Ruta, et al.
Publicado: (2018)

Clozapine treatment and risk of severe COVID‐19 infection
por: Ohlis, Anna, et al.
Publicado: (2021)

Clozapine treatment and risk of COVID-19 infection: retrospective cohort study
por: Govind, Risha, et al.
Publicado: (2021)

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016)

Clinical Audit of Clozapine Prescribing Practice and Monitoring Process in an Australian Community Mental Health Service
por: Fernando, Tharushi, et al.
Publicado: (2022)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Mandatory certification for clozapine prescribing
por: Cohen, Dan, et al.
Publicado: (2020)

Clozapine and all‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study
por: Cho, J., et al.
Publicado: (2018)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
por: Shirazi, Ayala, et al.
Publicado: (2016)

Prescribing issues experienced by people living with phenylketonuria in the UK
por: Ford, Suzanne, et al.
Publicado: (2019)

Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?
por: Blackman, Graham, et al.
Publicado: (2021)

Physical health monitoring after rapid tranquillisation: clinical practice in UK mental health services
por: Paton, Carol, et al.
Publicado: (2019)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine
por: Fonseca de Freitas, Daniela, et al.
Publicado: (2022)

Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
por: Legge, Sophie E., et al.
Publicado: (2016)

Clozapine clinics in north Wales - service evaluation audit
por: Raja, Jawad, et al.
Publicado: (2021)

Audit of therapeutic drug monitoring of ‘clozapine plasma levels’
por: Bellam, Shakina, et al.
Publicado: (2021)

COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine
por: Govind, Risha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2lvbpmgd51hg206p4c9a8b7b53